Global Clinical Trial Imaging Supply, Demand and Key Producers, 2023-2029

Global Clinical Trial Imaging Supply, Demand and Key Producers, 2023-2029

The global Clinical Trial Imaging market size is expected to reach $ 2215.1 million by 2029, rising at a market growth of 6.6% CAGR during the forecast period (2023-2029).

Global core clinical trial imaging manufacturers include Clario, ICON, McLaren, Calyx and BioTelemetry. The top 5 companies hold a share about 60%. North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific both with the share about 27%. In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.

This report studies the global Clinical Trial Imaging demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Clinical Trial Imaging, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Clinical Trial Imaging that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Clinical Trial Imaging total market, 2018-2029, (USD Million)

Global Clinical Trial Imaging total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Clinical Trial Imaging total market, key domestic companies and share, (USD Million)

Global Clinical Trial Imaging revenue by player and market share 2018-2023, (USD Million)

Global Clinical Trial Imaging total market by Type, CAGR, 2018-2029, (USD Million)

Global Clinical Trial Imaging total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Clinical Trial Imaging market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints and Radiant Sage, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Clinical Trial Imaging market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Clinical Trial Imaging Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Clinical Trial Imaging Market, Segmentation by Type
In-house Imaging Service
Central Imaging Service

Global Clinical Trial Imaging Market, Segmentation by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others

Companies Profiled:
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO

Key Questions Answered

1. How big is the global Clinical Trial Imaging market?

2. What is the demand of the global Clinical Trial Imaging market?

3. What is the year over year growth of the global Clinical Trial Imaging market?

4. What is the total value of the global Clinical Trial Imaging market?

5. Who are the major players in the global Clinical Trial Imaging market?

6. What are the growth factors driving the market demand?